Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2012

01-04-2012 | Article

Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study

Authors: V. G. Alexiou, A. Michalopoulos, G. C. Makris, G. Peppas, G. Samonis, M. E. Falagas

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2012

Login to get access

Abstract

We sought to identify risk factors for postoperative infections, caused by multi-drug-resistant gram-negative bacteria (MDR-GNB) in surgical patients. This was a retrospective cohort study among patients hospitalized in the intensive care unit (ICU) for more than 5 days, following general surgical operations. Comparison of patients who developed infection caused by MDR-GNB with the remainder of the cohort showed that every minute of operative time, use of special treatments during hospitalization (antineoplastic, immunosuppressive or immunomodulating therapies), every day of metronidazole, and every day of carbapenems use, increased patients’ odds to acquire an infection caused by MDR-GNB by 0.7%, 8.9 times, 9%, and 9%, respectively [OR (95% CI): 1.007 (1.003–1.011), p = 0.001; 8.9 (1.8–17.3), p = 0.004; 1.09 (1.04–1.18), p = 0.039; 1.09 (1.01–1.18), p = 0.023, respectively]. The above were adjusted in the multivariable analysis for the confounder of time distribution of infections caused by MDR-GNB. Finally, the secondary comparison, with patients that did not develop any infection, showed that patients who had received antibiotics, within 3 months prior to admission, had 3.8 times higher odds to acquire an infection caused by MDR-GNB [OR (95% CI): 3.8 (1.07–13.2), p = 0.002]. This study depicts certain, potentially modifiable, risk factors for postoperative infections in patients hospitalized in the ICU for more than 5 days.
Literature
1.
go back to reference Klevens RM, Edwards JR, Richards CL Jr et al (2007) Estimating health care-associated infections and deaths in U.S. Hospitals, 2002. Public Health Rep 122:160–166PubMed Klevens RM, Edwards JR, Richards CL Jr et al (2007) Estimating health care-associated infections and deaths in U.S. Hospitals, 2002. Public Health Rep 122:160–166PubMed
2.
go back to reference Paun BC, Cassie S, MacLean AR et al (2010) Postoperative complications following surgery for rectal cancer. Ann Surg 251(Suppl 5):807–818PubMedCrossRef Paun BC, Cassie S, MacLean AR et al (2010) Postoperative complications following surgery for rectal cancer. Ann Surg 251(Suppl 5):807–818PubMedCrossRef
3.
go back to reference Delgado-Rodríguez M, Gómez-Ortega A et al (1999) Nosocomial infection, indices of intrinsic infection risk, and in-hospital mortality in general surgery. J Hosp Infect 41(Suppl 3):203–211PubMedCrossRef Delgado-Rodríguez M, Gómez-Ortega A et al (1999) Nosocomial infection, indices of intrinsic infection risk, and in-hospital mortality in general surgery. J Hosp Infect 41(Suppl 3):203–211PubMedCrossRef
4.
go back to reference Richards MJ, Edwards JR, Culver DH, Gaynes RP (2000) Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21(Suppl 8):510–515PubMedCrossRef Richards MJ, Edwards JR, Culver DH, Gaynes RP (2000) Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 21(Suppl 8):510–515PubMedCrossRef
5.
go back to reference Lee CY, Chen PY, Huang FL, Lin CF (2009) Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center—6 years' experience. J Microbiol Immunol Infect 42(Suppl 2):160–165PubMed Lee CY, Chen PY, Huang FL, Lin CF (2009) Microbiologic spectrum and susceptibility pattern of clinical isolates from the pediatric intensive care unit in a single medical center—6 years' experience. J Microbiol Immunol Infect 42(Suppl 2):160–165PubMed
6.
go back to reference Gaynes R, Edwards JR (2005) National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41:848–854PubMedCrossRef Gaynes R, Edwards JR (2005) National Nosocomial Infections Surveillance System. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41:848–854PubMedCrossRef
7.
go back to reference Peleg AY, Hooper DC (2010) Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 362(Suppl 19):1804–1813PubMedCrossRef Peleg AY, Hooper DC (2010) Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 362(Suppl 19):1804–1813PubMedCrossRef
8.
go back to reference Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassopoulou P, Michalopoulos A (2005) Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 5:24PubMedCrossRef Falagas ME, Bliziotis IA, Kasiakou SK, Samonis G, Athanassopoulou P, Michalopoulos A (2005) Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infect Dis 5:24PubMedCrossRef
9.
go back to reference Falagas ME, Rafailidis PI, Ioannidou E et al (2010) Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 35(Suppl 2):194–199PubMedCrossRef Falagas ME, Rafailidis PI, Ioannidou E et al (2010) Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients. Int J Antimicrob Agents 35(Suppl 2):194–199PubMedCrossRef
10.
go back to reference Boucher HW, Talbot GH, Bradley JS et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1–12PubMedCrossRef Boucher HW, Talbot GH, Bradley JS et al (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1–12PubMedCrossRef
11.
go back to reference Falagas ME, Karageorgopoulos DE (2008) Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 46(Suppl 7):1121–1122PubMedCrossRef Falagas ME, Karageorgopoulos DE (2008) Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology. Clin Infect Dis 46(Suppl 7):1121–1122PubMedCrossRef
12.
go back to reference Falagas ME, Kopterides P (2006) Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64:7–15PubMedCrossRef Falagas ME, Kopterides P (2006) Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect 64:7–15PubMedCrossRef
13.
go back to reference del Mar TM, Cartelle M, Pertega S et al (2005) Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 11:540–546CrossRef del Mar TM, Cartelle M, Pertega S et al (2005) Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection. Clin Microbiol Infect 11:540–546CrossRef
14.
go back to reference Carbonne A, Naas T, Blanckaert K et al (2005) Investigation of a nosocomial outbreak of extended-spectrum betalactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting. J Hosp Infect 60:14–18PubMedCrossRef Carbonne A, Naas T, Blanckaert K et al (2005) Investigation of a nosocomial outbreak of extended-spectrum betalactamase VEB-1-producing isolates of Acinetobacter baumannii in a hospital setting. J Hosp Infect 60:14–18PubMedCrossRef
15.
go back to reference Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y (2005) Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 11:22–29PubMedCrossRef Abbo A, Navon-Venezia S, Hammer-Muntz O, Krichali T, Siegman-Igra Y, Carmeli Y (2005) Multidrug-resistant Acinetobacter baumannii. Emerg Infect Dis 11:22–29PubMedCrossRef
16.
go back to reference Garnacho-Montero J, Ortiz-Leyba C, Fernández-Hinojosa E et al (2005) Acinetobacter baumannii ventilator associated pneumonia: epidemiological and clinical findings. Intensive Care Med 31:649–655PubMedCrossRef Garnacho-Montero J, Ortiz-Leyba C, Fernández-Hinojosa E et al (2005) Acinetobacter baumannii ventilator associated pneumonia: epidemiological and clinical findings. Intensive Care Med 31:649–655PubMedCrossRef
17.
go back to reference Nseir S, Di Pompeo C, Soubrier S et al (2005) First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33:283–289PubMedCrossRef Nseir S, Di Pompeo C, Soubrier S et al (2005) First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33:283–289PubMedCrossRef
18.
go back to reference Maslow JN, Glaze T, Adams P, Lataillade M (2005) Concurrent outbreak of multidrug-resistant and susceptible subclones of Acinetobacter baumannii affecting different wards of a single hospital. Infect Control Hosp Epidemiol 26:69–75PubMedCrossRef Maslow JN, Glaze T, Adams P, Lataillade M (2005) Concurrent outbreak of multidrug-resistant and susceptible subclones of Acinetobacter baumannii affecting different wards of a single hospital. Infect Control Hosp Epidemiol 26:69–75PubMedCrossRef
19.
go back to reference Maragakis LL, Cosgrove SE, Song X et al (2004) An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 292:3006–3011PubMedCrossRef Maragakis LL, Cosgrove SE, Song X et al (2004) An outbreak of multidrug-resistant Acinetobacter baumannii associated with pulsatile lavage wound treatment. JAMA 292:3006–3011PubMedCrossRef
20.
go back to reference Lee SO, Kim NJ, Choi SH, Hyong Kim T et al (2004) Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 48:224–248PubMedCrossRef Lee SO, Kim NJ, Choi SH, Hyong Kim T et al (2004) Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 48:224–248PubMedCrossRef
21.
go back to reference Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA (2002) Risk factors for piperacillintazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother 46:854–858PubMedCrossRef Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA (2002) Risk factors for piperacillintazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother 46:854–858PubMedCrossRef
22.
go back to reference Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC (2002) Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 34:340–345PubMedCrossRef Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC (2002) Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 34:340–345PubMedCrossRef
23.
go back to reference Lee SC, Fung CP, Liu PY et al (1999) Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome. Infect Control Hosp Epidemiol 20:205–207PubMedCrossRef Lee SC, Fung CP, Liu PY et al (1999) Nosocomial infections with ceftazidime-resistant Pseudomonas aeruginosa: risk factors and outcome. Infect Control Hosp Epidemiol 20:205–207PubMedCrossRef
24.
go back to reference Troillet N, Samore MH, Carmeli Y (1997) Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis 25:1094–1098PubMedCrossRef Troillet N, Samore MH, Carmeli Y (1997) Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis 25:1094–1098PubMedCrossRef
25.
go back to reference Peersman G, Laskin R, Davis J, Peterson MG, Richart T (2006) Prolonged operative time correlates with increased infection rate after total knee arthroplasty. HSS J 2(Suppl 1):70–72PubMedCrossRef Peersman G, Laskin R, Davis J, Peterson MG, Richart T (2006) Prolonged operative time correlates with increased infection rate after total knee arthroplasty. HSS J 2(Suppl 1):70–72PubMedCrossRef
26.
go back to reference Horan TC, Gaynes RP (2004) Surveillance of nosocomial infections. In: Mayhall CG (ed) Hospital epidemiology and infection control, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 1659–1702 Horan TC, Gaynes RP (2004) Surveillance of nosocomial infections. In: Mayhall CG (ed) Hospital epidemiology and infection control, 3rd edn. Lippincott Williams & Wilkins, Philadelphia, pp 1659–1702
27.
go back to reference Iversen LH, Bülow S, Christensen IJ, Laurberg S, Harling H, Danish Colorectal Cancer Group (2008) Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer. Br J Surg 95(Suppl 8):1012–1019PubMedCrossRef Iversen LH, Bülow S, Christensen IJ, Laurberg S, Harling H, Danish Colorectal Cancer Group (2008) Postoperative medical complications are the main cause of early death after emergency surgery for colonic cancer. Br J Surg 95(Suppl 8):1012–1019PubMedCrossRef
28.
go back to reference Haridas M, Malangoni MA (2008) Predictive factors for surgical site infection in general surgery. Surgery 144(Suppl 4):496–503PubMedCrossRef Haridas M, Malangoni MA (2008) Predictive factors for surgical site infection in general surgery. Surgery 144(Suppl 4):496–503PubMedCrossRef
29.
go back to reference Neumayer L, Hosokawa P, Itani K, El-Tamer M, Henderson WG, Khuri SF (2007) Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg 204(Suppl 6):1178–1187PubMedCrossRef Neumayer L, Hosokawa P, Itani K, El-Tamer M, Henderson WG, Khuri SF (2007) Multivariable predictors of postoperative surgical site infection after general and vascular surgery: results from the patient safety in surgery study. J Am Coll Surg 204(Suppl 6):1178–1187PubMedCrossRef
30.
go back to reference Brown S, Kurtsikashvili G, Alonso-Echanove J et al (2007) Prevalence and predictors of surgical site infection in Tbilisi, Republic of Georgia. J Hosp Infect 66(Suppl 2):160–166PubMedCrossRef Brown S, Kurtsikashvili G, Alonso-Echanove J et al (2007) Prevalence and predictors of surgical site infection in Tbilisi, Republic of Georgia. J Hosp Infect 66(Suppl 2):160–166PubMedCrossRef
31.
go back to reference Fariñas-Alvarez C, Fariñas MC, Fernández-Mazarrasa C, Llorca J, Casanova D, Delgado-Rodríguez M (2000) Analysis of risk factors for nosocomial sepsis in surgical patients. Br J Surg 87(Suppl 8):1076–1081PubMedCrossRef Fariñas-Alvarez C, Fariñas MC, Fernández-Mazarrasa C, Llorca J, Casanova D, Delgado-Rodríguez M (2000) Analysis of risk factors for nosocomial sepsis in surgical patients. Br J Surg 87(Suppl 8):1076–1081PubMedCrossRef
32.
go back to reference Jeon MH, Choi SH, Kwak YG et al (2008) Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagn Microbiol Infect Dis 62(Suppl 4):402–406PubMedCrossRef Jeon MH, Choi SH, Kwak YG et al (2008) Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients. Diagn Microbiol Infect Dis 62(Suppl 4):402–406PubMedCrossRef
33.
go back to reference Edmond MB, Ober JF, Weinbaum DL et al (1995) Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 20(Suppl 5):1126–1133PubMedCrossRef Edmond MB, Ober JF, Weinbaum DL et al (1995) Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 20(Suppl 5):1126–1133PubMedCrossRef
34.
go back to reference Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD (1998) Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 26(Suppl 5):1127–1133PubMedCrossRef Lucas GM, Lechtzin N, Puryear DW, Yau LL, Flexner CW, Moore RD (1998) Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis 26(Suppl 5):1127–1133PubMedCrossRef
35.
go back to reference Wells CL, Maddaus MA, Reynolds CM, Jechorek RP, Simmons RL (1987) Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun 55(Suppl 11):2689–2694PubMed Wells CL, Maddaus MA, Reynolds CM, Jechorek RP, Simmons RL (1987) Role of anaerobic flora in the translocation of aerobic and facultatively anaerobic intestinal bacteria. Infect Immun 55(Suppl 11):2689–2694PubMed
36.
go back to reference Wells CL, Jechorek RP, Maddaus MA, Simmons RL (1988) Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice. Antimicrob Agents Chemother 32(Suppl 12):1769–1775PubMed Wells CL, Jechorek RP, Maddaus MA, Simmons RL (1988) Effects of clindamycin and metronidazole on the intestinal colonization and translocation of enterococci in mice. Antimicrob Agents Chemother 32(Suppl 12):1769–1775PubMed
37.
go back to reference Wells CL, Maddaus MA, Jechorek RP, Simmons RL (1988) Role of intestinal anaerobic bacteria in colonization resistance. Eur J Clin Microbiol Infect Dis 7(Suppl 1):107–113PubMedCrossRef Wells CL, Maddaus MA, Jechorek RP, Simmons RL (1988) Role of intestinal anaerobic bacteria in colonization resistance. Eur J Clin Microbiol Infect Dis 7(Suppl 1):107–113PubMedCrossRef
38.
go back to reference Chastre J, Wolff M, Fagon JY, Chevret S et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290(Suppl 19):2588–2598PubMedCrossRef Chastre J, Wolff M, Fagon JY, Chevret S et al (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290(Suppl 19):2588–2598PubMedCrossRef
39.
go back to reference Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162:505–511PubMed Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit: A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162:505–511PubMed
40.
go back to reference Nseir S, Di Pompeo C, Soubrier S et al (2005) First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33:283–289PubMedCrossRef Nseir S, Di Pompeo C, Soubrier S et al (2005) First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 33:283–289PubMedCrossRef
41.
go back to reference Donaldson AD, Razak L, Liang LJ, Fisher DA, Tambyah PA (2009) Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter? Int J Antimicrob Agents 34(Suppl 3):246–251PubMedCrossRef Donaldson AD, Razak L, Liang LJ, Fisher DA, Tambyah PA (2009) Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter? Int J Antimicrob Agents 34(Suppl 3):246–251PubMedCrossRef
42.
go back to reference Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379PubMedCrossRef Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49(12):1373–1379PubMedCrossRef
Metadata
Title
Multi-drug-resistant gram-negative bacterial infection in surgical patients hospitalized in the ICU: a cohort study
Authors
V. G. Alexiou
A. Michalopoulos
G. C. Makris
G. Peppas
G. Samonis
M. E. Falagas
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2012
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-011-1347-2

Other articles of this Issue 4/2012

European Journal of Clinical Microbiology & Infectious Diseases 4/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.